RE:RE:Advisory Committee and FDA Approval
To answer my own question, 70% of "Priority Review" submissions receive a yes vote at Adcomm. Of those, in the time frame GMB's analysis covered, 100% of those receiving a yes vote go on to receive final approval from the FDA. Slightly better odds than HT's coin flip, but still not quite a slam dunk. Apparently safety and 3rd party payer status could have quite an influence on the ultimate vote and decision. At least that is how I read things.